Soleno Therapeutics
SLNO
#4349
Rank
NZ$4.79 B
Marketcap
NZ$92.05
Share price
0.00%
Change (1 day)
7.75%
Change (1 year)

Earnings for Soleno Therapeutics (SLNO)

Earnings in 2026 (TTM): NZ$0.18 Billion

According to Soleno Therapeutics's latest financial reports the company's current earnings are NZ$0.28 Billion. In 2025 the company made an earning of NZ$45.78 Million, an increase over its 2024 earnings that were of -NZ$0.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soleno Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.18 B297.3%
2025 NZ$45.78 M-115.52%
2024 -NZ$0.3 Billion339.22%
2023 -NZ$67.16 Million54.01%
2022 -NZ$43.61 Million-22.16%
2021 -NZ$56.02 Million0.97%
2020 -NZ$55.48 Million37.73%
2019 -NZ$40.29 Million96.94%
2018 -NZ$20.46 Million21.69%
2017 -NZ$16.81 Million-23.69%
2016 -NZ$22.03 Million-20.82%
2015 -NZ$27.82 Million86%
2014 -NZ$14.96 Million829.91%
2013 -NZ$1.61 Million